by Kayla Mossien | May 31, 2021 | Articles, Causal, Clinical Trials, Featured Posts, Journals
Likhitha Kolla, Fred K. Gruber, Omar Khalid, Colin Hill, Ravi B. Parikh
by Simona Gilman | Jun 25, 2020 | Featured Posts, Press Releases
A transformative innovation GeminiTM, the in silico patient, will drive better drug development, clinical trial design and generation of real-world evidence in multiple myeloma GNS Healthcare, an AI-driven precision medicine company, today announced the launch of...
by Caitlin Nicholson | Feb 24, 2020 | Articles, Cardiometabolic, Causal, Featured Posts, Journals
Luke Mueller, Paulos Berhanu, Jonathan Bouchard, Veronica Alas, Kenneth Elder, Ngoc Thai, Cody Hitchcock, Tiffany Hadzi, Iya Khalil, Lesley-Ann Miller-Wilson
by Simona Gilman | Feb 18, 2020 | Articles, Featured Posts, Oncology
Mike J. Mason ● Carolina Schinke ● Christine L. P. Eng ● Fadi Towfic ● Fred Gruber ● Andrew Dervan ● Brian S. White ● Aditya Pratapa ● Yuanfang Guan8 ● Hongjie Chen ● Yi Cui10 ● Bailiang Li ● Thomas Yu ● Elias Chaibub Neto ● Konstantinos Mavrommatis ● Maria Ortiz ●...
by wpengine | Jan 8, 2020 | Featured Posts, News
Peggy Maguire, president of Cambia Health Foundation, shares how Cambia worked with GNS to use predictive analytics and identify members of Cambia’s Medicare Advantage population that could benefit from an extra layer of support. Read the full article...
by Simona Gilman | Jan 5, 2020 | Featured Posts, Press Releases
Merck GHI joins leading biopharma companies Amgen, BMS, Zambon Pharmaceuticals, and leading health plans Cigna, Cambia Health Solutions, Echo Health Ventures, Horizon Blue Cross of NJ, and Heritage Provider Network, as an investor in GNS Healthcare. CAMBRIDGE, Mass. –...
